E. Knight

4.1k total citations
45 papers, 3.4k citations indexed

About

E. Knight is a scholar working on Molecular Biology, Immunology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, E. Knight has authored 45 papers receiving a total of 3.4k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Molecular Biology, 12 papers in Immunology and 8 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in E. Knight's work include interferon and immune responses (7 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and RNA and protein synthesis mechanisms (7 papers). E. Knight is often cited by papers focused on interferon and immune responses (7 papers), Monoclonal and Polyclonal Antibodies Research (7 papers) and RNA and protein synthesis mechanisms (7 papers). E. Knight collaborates with scholars based in United States. E. Knight's co-authors include R. W. F. Hardy, D Fahey, Bruce D. Korant, Gerald J. Jonak, Ernest C. Borden, James Darnell, Jonathan D’Cunha, Dale C. Blomstrom, Nancy C. Reich and Beverly C. Cordova and has published in prestigious journals such as Nature, Science and Proceedings of the National Academy of Sciences.

In The Last Decade

E. Knight

44 papers receiving 3.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
E. Knight United States 27 1.8k 1.5k 967 290 245 45 3.4k
Regine Kraft Germany 39 1.9k 1.1× 4.3k 2.8× 1.2k 1.3× 167 0.6× 440 1.8× 91 6.6k
Nicola Tinari Italy 35 2.2k 1.2× 2.0k 1.3× 1.5k 1.6× 253 0.9× 222 0.9× 120 5.1k
Takashi Murata Japan 38 1.1k 0.6× 2.0k 1.3× 408 0.4× 210 0.7× 117 0.5× 134 4.6k
Barry Cherney United States 26 818 0.5× 1.6k 1.1× 866 0.9× 366 1.3× 135 0.6× 46 2.6k
Yves St‐Pierre Canada 42 1.6k 0.9× 3.0k 2.0× 953 1.0× 266 0.9× 182 0.7× 153 5.3k
Lukas C. Kühn Switzerland 47 522 0.3× 4.4k 2.9× 457 0.5× 350 1.2× 220 0.9× 90 8.0k
G C Dubois United States 24 826 0.5× 2.1k 1.4× 862 0.9× 177 0.6× 300 1.2× 47 3.7k
Sumio Tanase Japan 35 515 0.3× 1.7k 1.1× 510 0.5× 86 0.3× 270 1.1× 91 3.2k
Manish S. Patankar United States 35 1.5k 0.8× 1.9k 1.3× 798 0.8× 354 1.2× 155 0.6× 99 4.6k
Shaodong Dai United States 30 902 0.5× 1.5k 1.0× 292 0.3× 174 0.6× 159 0.6× 61 2.9k

Countries citing papers authored by E. Knight

Since Specialization
Citations

This map shows the geographic impact of E. Knight's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by E. Knight with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites E. Knight more than expected).

Fields of papers citing papers by E. Knight

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by E. Knight. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by E. Knight. The network helps show where E. Knight may publish in the future.

Co-authorship network of co-authors of E. Knight

This figure shows the co-authorship network connecting the top 25 collaborators of E. Knight. A scholar is included among the top collaborators of E. Knight based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with E. Knight. E. Knight is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Knight, E., et al.. (2001). Managed Care: Managed Care: Recovery Enhancer or Inhibitor?. Psychiatric Services. 52(1). 25–26. 7 indexed citations
2.
D’Cunha, Jonathan, et al.. (1996). In vitro and in vivo secretion of human ISG15, an IFN-induced immunomodulatory cytokine. The Journal of Immunology. 157(9). 4100–4108. 193 indexed citations
3.
Knight, E., et al.. (1995). Membranes of Human Neuroblastoma SH-SY5Y Cells Contain Specific Binding Sites for [3H] K-252A. Biochemical and Biophysical Research Communications. 211(2). 511–518. 2 indexed citations
4.
Vignaux, F, et al.. (1991). An Interferon-Induced 16-kD Protein Is Present in the Membranes of Interferon-Sensitive but Not in Interferon-Resistant Mouse Cells. Journal of Interferon Research. 11(3). 123–130. 2 indexed citations
5.
Recht, Michael, Ernest C. Borden, & E. Knight. (1991). A human 15-kDa IFN-induced protein induces the secretion of IFN-gamma. The Journal of Immunology. 147(8). 2617–2623. 155 indexed citations
6.
Knight, E. & Beverly C. Cordova. (1991). IFN-induced 15-kDa protein is released from human lymphocytes and monocytes. The Journal of Immunology. 146(7). 2280–2284. 107 indexed citations
7.
Jonak, Gerald J., et al.. (1987). Regulation of c- myc RNA and Its Proteins in Daudi Cells by Interferon-β. Journal of Interferon Research. 7(1). 41–52. 10 indexed citations
8.
Knight, E.. (1987). Purification of the Interferons. Journal of Interferon Research. 7(5). 501–503. 2 indexed citations
9.
Blomstrom, Dale C., D Fahey, Rusty Kutny, Bruce D. Korant, & E. Knight. (1986). Molecular characterization of the interferon-induced 15-kDa protein. Molecular cloning and nucleotide and amino acid sequence.. Journal of Biological Chemistry. 261(19). 8811–8816. 141 indexed citations
10.
Jonak, Gerald J. & E. Knight. (1984). Selective reduction of c-myc mRNA in Daudi cells by human beta interferon.. Proceedings of the National Academy of Sciences. 81(6). 1747–1750. 115 indexed citations
11.
Knight, E. & D Fahey. (1982). Human Interferon-Beta: Effects of Deglycosylation. Journal of Interferon Research. 2(3). 421–429. 27 indexed citations
12.
Knight, E. & D Fahey. (1981). Human fibroblast interferon. An improved purification.. Journal of Biological Chemistry. 256(8). 3609–3611. 56 indexed citations
13.
Knight, E., Michael W. Hunkapiller, Bruce D. Korant, R. W. F. Hardy, & Leroy Hood. (1980). Human Fibroblast Interferon: Amino Acid Analysis and Amino Terminal Amino Acid Sequence. Science. 207(4430). 525–526. 142 indexed citations
14.
Knight, E.. (1978). Preparation of 125Iodine-labelled Human Fibroblast Interferon. Journal of General Virology. 40(3). 681–684. 14 indexed citations
15.
Knight, E.. (1976). Interferon: purification and initial characterization from human diploid cells.. Proceedings of the National Academy of Sciences. 73(2). 520–523. 135 indexed citations
16.
Knight, E.. (1974). Interferon-Sepharose: priming of L Cells for Induction of Interferon by MM Virus. Journal of General Virology. 25(1). 143–145. 7 indexed citations
17.
Knight, E.. (1973). INTERFERON: EFFECT ON THE SATURATION DENSITY TO WHICH MOUSE CELLS WILL GROW IN VITRO. The Journal of Cell Biology. 56(3). 846–849. 15 indexed citations
18.
Yin, F H & E. Knight. (1972). In Vivo and In Vitro Synthesis of Human Rhinovirus Type 2 Ribonucleic Acid. Journal of Virology. 10(1). 93–98. 24 indexed citations
19.
Knight, E., et al.. (1971). E. Coli Transfer RNA: Fractionation By Electrophoresis on Polyacrylamide Gel. Preparative Biochemistry. 1(1). 19–36. 1 indexed citations
20.
Knight, E., et al.. (1965). Stimulation of Pyrophosphatase Activity in Clostridium pasteurianum by Reductants. Journal of Bacteriology. 90(1). 288–289. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026